A Wide variety of non-operative treatments are advocated in management of lumbar disc herniations. Unfortunately the multiplicity of treatment methods implies the absence of a clearly superior treatment program. Because of the great expense created by the chaotic array of conservative care measures and arbitrary selection of these measures by different subspecialist, Quebec Task Force, the Agency for Health Care Policy and Research, AAOS/NASS spine Algorithm Task Force developed the guidelines for conservative treatments. It is generally accepted that past medical recommendations may have been overly cautious in returning patients to activity to their possible detriment, thereby slowing recovering and worsening prognosis were resulted. Therefore there is a shifts towards more active therapy with involvement of the patient in various excercise programs recently. In this articles various conservative treatments were reviewed in order to help in managing the patient with lumbar disc herniation.
Advisory Committees ; Humans ; Prognosis ; Quebec ; Spine ; United States Agency for Healthcare Research and Quality

Registry studies (RS) get more and more attention in recent years because it can reflect the health care situations of the real world. There are a number of large scale RS for traditional Chinese medicine (TCM). RS are observational studies that can complement randomized controlled trials (RCT). RS have an irreplaceable position in real word study (RWS), especially for small probability events. There are some different characters and qualities in RS. Registries for Evaluating Patient Outcomes: A User's Guide (2nd Edition) was published by the agency for healthcare research and quality (AHRQ) in 2010. It described the details of how to establish, maintain, and evaluate RS, and using 38 RS samples to illustrate the possible problems in undertaking such research. The User's Guide (2nd Edition) provides a reliable reference document for RS. TCM injections post-marketing safety surveillance RS is a national program involving multiple centers in China. This program can further improve RS quality their application in China and is a good illustration of how to follow this guide accurately.
Books ; Drug Therapy ; Drugs, Chinese Herbal ; standards ; therapeutic use ; Humans ; Observational Studies as Topic ; Outcome Assessment (Health Care) ; organization & administration ; standards ; Patient Selection ; Pragmatic Clinical Trials as Topic ; Registries ; standards ; United States ; United States Agency for Healthcare Research and Quality